Saturday, November 9, 2024
- Advertisement -spot_img

TAG

RMD

ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits

Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound...

Latest news

- Advertisement -spot_img